LONDON, April 14 /PRNewswire/ --

- ATTN: Yorkshire Editors

A Group of people with multiple sclerosis (MS) in Yorkshire are being denied access to a vital drug that has been proved to be the most effective treatment for their condition.

Mid Yorkshire Hospitals NHS Trust has failed to provide people living with a rapidly evolving and severe form of MS access to Tysabri despite being legally required to do so by the Government's drugs watchdog.

MS is the most common disabling and incurable neurological disorder affecting the central nervous system in young adults.

Succession is one of the first things that students learn about in ecology. Each intervening stage modifies the environment in such a way that lays the groundwork for the next stage, while making the environment less hospitable to its own offspring. Only the final stage is self-perpetuating and stable.

Frederic Clements, one of the pioneers of community ecology, saw ecological succession as an ontogenic process in which the community - a superorganism - developed into its final, mature form. The orderly progression from bare ground to mature forest is orderly, progressive…and very Victorian.

Each copy of the human genome consists of about 3,200,000,000 base pairs, and includes about 500,000 repeats of the LINE-1 transposable element (a LINE) and twice as many copies of Alu (a SINE), as compared to around 20,000 protein-coding genes.

Whereas protein-coding regions represent about 1.5% of the genome, about half is made up LINE-1, Alu, and other transposable element sequences. These begin as parasites, and some continue to behave as detrimental mutagens implicated in disease. However, most of those in the human genome are no longer mobile, and it is possible that many of these persist as commensal freeloaders.

Finally, it has long been expected that a significant subset of non-coding elements would be co-opted by the host and take on functional roles at the organism level, and there is increasing evidence to support this. A notable fraction of the non-genic portion of human DNA is undoubtedly involved in regulation, chromosomal function, and other important processes, but based on what we know about non-coding DNA sequences, it remains a reasonable default assumption -- though one that should continue to be tested empirically -- that much or perhaps most of it is not functional at the organism level.

This does not mean that a search for the functional segments is futile or irrelevant -- far from it, as many non-genic regions are critical for normal genomic operation and some have played an important role in many evolutionary transitions. It simply means that one must not extrapolate without warrant from discoveries involving a small fraction of sequences to the genome as a whole.

BAD HOMBURG, Germany, April 14 /PRNewswire/ --

- Campaign to Improve Treatment of Children With Diabetes

Each year, more and more children and adolescents all over the world are diagnosed with type 1 diabetes. The overall annual increase is estimated at around 3%(1). However, even in countries with highly developed health care systems, the care received by young people with diabetes is not always optimal. This is what SWEET intends to change: SWEET is the first project aimed at improving the diagnosis and care of children and adolescents with diabetes in Europe in order to prevent costly and debilitating secondary disorders. The initiative, which is subsidised by the EU, was kick-started on April 9th in Bad Homburg, Germany.

CALGARY, Canada, April 14 /PRNewswire/ --

- Natural Hydresia(TM) G2 Offers Enhanced Formulation Flexibility With a Globally Accepted Preservative System

AMSTERDAM, April 14 /PRNewswire/ --

- New and Forthcoming Enhancements Designed to Optimize Research Workflows

Elsevier, a leading publisher of Scientific, technical and medical (STM) information, today announced that new intuitive reference and navigational features have been added to its online STM platform, ScienceDirect. The new features, which were developed in cooperation with researchers, deliver clearer results with fewer clicks. Additionally, researcher comments and ratings from 2collab, Elsevier's free Web-based collaborative platform, will be integrated with the articles in ScienceDirect. With this upgrade researchers will experience a boost in productivity and a faster and more seamless research process.

Navigational Improvements

ZWOLLE, The Netherlands, April 14 /PRNewswire/ -- Capital ID, specialist in marketing operations management (MOM), announces the further expansion of its business to North America, the United Kingdom and Continental Europe. Richard Goat and Jerry Gilroy have joined the Capital ID team to drive international success. Jerry will focus on European and International business expansion, whereas Richard will address the North American marketplace.

Richard Goat, President Capital ID, Inc.

SANTA MONICA, California, April 14 /PRNewswire/ --

The Save the Titanic Foundation (www.savethetitanic.org) announced it has been awarded the President's Volunteer Service Award. The President's Volunteer Service Award (PVSA) is an award given by the President of the United States to recognize the valuable contributions made by volunteers across the nation. The award will be distributed at the CelebrateLA volunteer recognition event that will be held at the Rose Bowl Stadium in Pasadena, California on April 27, 2008.

FRAZER, Pennsylvania and MAISONS-ALFORT, France, April 14 /PRNewswire/ --

Cephalon, Inc. (Nasdaq: CEPH) announced today that the European Commission has granted marketing authorization for EFFENTORA(TM), a buccal tablet formulation of fentanyl. EFFENTORA is indicated for the treatment of breakthrough cancer pain (BTCP) in adult patients who are already receiving maintenance opioid therapy for chronic pain. The approval allows Cephalon to market EFFENTORA in the 27 member states of the European Union (EU), as well as Iceland and Norway.

TARRYTOWN, New York, April 14 /PRNewswire/ --

On2 Technologies, Inc. (Amex: ONT), a leader in video compression technologies, announced today it has licensed its Flix(R) Engine encoding and publishing platform to Eurosport, a leading on-line sports brand. By using Flix Engine, Eurosport will standardize its online video programming to On2 based video for Adobe(R) Flash(R), and will migrate its archive programming across Europe and China to the On2 format.